Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
50 hedge funds and large institutions have $30.8M invested in Applied Genetic Technologies Corporation in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 21 reducing their positions, and 10 closing their positions.
11,933% more call options, than puts
Call options by funds: $722K | Put options by funds: $6K
58% more capital invested
Capital invested by funds: $19.5M → $30.8M (+$11.2M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 54 → 50 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
52% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
+$210K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$199K |
| 3 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$175K |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$158K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$152K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$601K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$420K |
| 3 |
Two Sigma Investments
New York
|
-$231K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$229K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$178K |
AGTC Hedge Fund Activity: Q1 2019 in Review
50 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q1 2019, worth a combined $30.8M — up 58% from $19.5M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of AGTC and 6 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 10 added.
The largest buyer was Altrinsic Global Advisors, adding an estimated $210K. The largest seller was AJO LP, exiting entirely with an estimated $601K sold.
- 50 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q1 2019, down from 54 in Q4 2018.
- Funds reported $30.8M of Applied Genetic Technologies Corporation stock for Q1 2019, up 58% quarter-over-quarter.
- 6 funds opened new Applied Genetic Technologies Corporation positions in Q1 2019 and 10 closed out, a net change of -4 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q1 2019 was Altrinsic Global Advisors, an estimated $210K added.
- The largest Applied Genetic Technologies Corporation seller in Q1 2019 was AJO LP, an estimated $601K sold.
Based on aggregated 13F filings for Q1 2019.